Coughlin Timothy

Travere Therapeutics, Inc. · Director

Coughlin Timothy is listed in public filings as director. This Coughlin Timothy insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Travere Therapeutics, Inc. (TVTX), aTyr Pharma, Inc. (ATYR), and ADC Therapeutics S.A. (ADCT). Investors use Coughlin Timothy's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$507k12k sharesGrant / ExerciseMay 19, 2026$507.1K12k shares$42.26--
Travere Therapeutics, Inc.TVTX--56.3k sharesGrant / ExerciseMay 19, 2026Disclosure amount unavailable4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$2.3M52.3k sharesSellMay 15, 2026$141.3K3.3k shares$43.49--
aTyr Pharma, Inc.ATYR$48k50k sharesGrant / ExerciseMay 11, 2026$47.5K50k shares$0.95--
Travere Therapeutics, Inc.TVTX$1.9M55.5k sharesSellOct 31, 2025$630.6K18k shares$35.03--
Travere Therapeutics, Inc.TVTX$010k sharesGrant / ExerciseOct 31, 2025$174.4K10k shares$17.44--
Travere Therapeutics, Inc.TVTX$08k sharesGrant / ExerciseOct 31, 2025$130.6K8k shares$16.33--
ADC Therapeutics S.A.ADCT$287k80k sharesGrant / ExerciseJun 3, 2025$287.2K80k shares$3.59--
ADC Therapeutics S.A.ADCT--40k sharesGrant / ExerciseJun 3, 2025Disclosure amount unavailable40k shares----
Travere Therapeutics, Inc.TVTX$412k19.5k sharesGrant / ExerciseMay 15, 2025$412.4K19.5k shares$21.15--
Travere Therapeutics, Inc.TVTX--55.5k sharesGrant / ExerciseMay 15, 2025Disclosure amount unavailable6.5k shares----
aTyr Pharma, Inc.ATYR$167k50k sharesGrant / ExerciseMay 1, 2025$167.0K50k shares$3.34--